Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000890766 | SCV001034538 | benign | not provided | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000114374 | SCV002802522 | likely benign | Retinitis pigmentosa 68 | 2022-03-31 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888508 | SCV004705724 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
OMIM | RCV000114374 | SCV000147988 | pathogenic | Retinitis pigmentosa 68 | 2014-03-27 | no assertion criteria provided | literature only | |
Reproductive Health Research and Development, |
RCV000114374 | SCV001142334 | pathogenic | Retinitis pigmentosa 68 | 2020-01-06 | no assertion criteria provided | curation | NM_020949.2:c.988G>A in the SLC7A14 gene has an allele frequency of 0.023 in East Asian subpopulation in the gnomAD database. This c.988G>A (p.Gly330Arg) variant has been observed in multiple individuals affected with autosomal recessive retinitis pigmentosa, including one in homozygous state and two in compound heterozygous state (PMID: 24670872). Experimental studies have shown that G330R expressing cells showed a diffuse pattern of Slc7a14 expression throughout the cytoplasm (PMID: 24670872). Pathogenic computational verdict because pathogenic predictions from DANN, DEOGEN2, EIGEN, FATHMM-MKL, MutationAssessor, MutationTaster, PrimateAI, REVEL and SIFT. Taken together, we interprete this variant as Pathogenic/Likely pathogenic variant. ACMG/AMP Criteria applied: PP3, PM3_Strong, PS3, BS1. |
Prevention |
RCV003935091 | SCV004755810 | likely benign | SLC7A14-related disorder | 2019-07-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |